NPI: 1700815487 · HAZLET, NJ 07730 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/03/2006
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/03/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,381 | $158K |
| 2019 | 6,337 | $785K |
| 2020 | 7,245 | $700K |
| 2021 | 4,715 | $185K |
| 2022 | 13,211 | $238K |
| 2023 | 6,275 | $91K |
| 2024 | 4,147 | $55K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | 20,816 | 1,459 | $1.36M | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,328 | 543 | $534K |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,582 | 317 | $170K |
| A4657 | Syringe, with or without needle, each | 3,176 | 1,090 | $49K |
| J1756 | Injection, iron sucrose, 1 mg | 2,733 | 493 | $30K |
| 85048 | 1,077 | 662 | $20K | |
| 85041 | 1,077 | 662 | $20K | |
| 83970 | 1,008 | 496 | $16K | |
| 82728 | 325 | 210 | $6K | |
| 83540 | 317 | 196 | $3K | |
| 83550 | 142 | 102 | $3K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 47 | 24 | $1.00 |
| 82306 | 13 | 12 | $1.00 | |
| 82108 | 35 | 24 | $1.00 | |
| G0008 | Administration of influenza virus vaccine | 22 | 12 | $0.00 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 452 | 183 | $0.00 |
| OP250 | 161 | 12 | $0.00 |